SCHEMBL31436088

SCHEMBL31436088

CCN(CCO)CCNc1nc(OCCCNC(=O)OC(C)(C)C)nc(OCCCNC(=O)OC(C)(C)C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
STK17B O94768 1/20 0.41
STK17A Q9UEE5 1/20 0.41
CA12 O43570 6/20 0.40
CA1 P00915 6/20 0.40
CA2 P00918 6/20 0.40
CA9 Q16790 6/20 0.40
TLR7 Q9NYK1 3/20 0.37
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
ADORA2B P29275 1/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36
IL6 P05231 2/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
DRD2 P14416 1/20 0.35
STING1 Q86WV6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31436047 0.94 STK17B (0.43) TDP1STK17BSTK17ACA12CA1
SCHEMBL31436104 0.88 TDP1 (0.43) TDP1STK17BSTK17ACA12CA1
SCHEMBL31436100 0.87 TDP1 (0.47) TDP1STK17BSTK17ACA12CA1
SCHEMBL31436057 0.80 STK17B (0.48) TDP1STK17BSTK17ACA12CA1
SCHEMBL11989404 0.78 TDP1 (0.61) TDP1CA12CA1CA2CA9
SCHEMBL31436053 0.78 TDP1 (0.50) TDP1STK17BSTK17ACA12CA1
SCHEMBL15889841 0.77 TDP1 (0.54) TDP1CA12CA1CA2CA9
SCHEMBL31436111 0.75 DRD2 (0.44) STK17BSTK17ACA12CA1CA2
SCHEMBL31436039 0.74 STK17B (0.57) TDP1STK17BSTK17ACA12CA1
SCHEMBL31436049 0.74 TDP1 (0.49) TDP1STK17BSTK17ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025088570-A1 IONIZABLE LIPIDS AND IONIZABLE LIPID NANOPARTICLES CRISPR THERAPEUTICS AG (CH) 2025-05-01 WO disclosed